4.8 Letter

Resistance Mutations in SARS-CoV-2 Delta Variant after Sotrovimab Use

Journal

NEW ENGLAND JOURNAL OF MEDICINE
Volume 386, Issue 15, Pages 1477-1479

Publisher

MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMc2120219

Keywords

-

Funding

  1. Prevention Research Support Program
  2. New South Wales (NSW) Ministry of Health
  3. NSW
  4. National Health and Medical Research Council, Australia [APPRISE 1116530]
  5. Institute of Clinical Pathology and Medical Research

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available